Telebionix is reimagining the future of healthcare and transforming digital health by measuring your daily health, providing AI-driven insights, and keeping you connected to your caregivers - all from the comfort of your home.
COVID-19 is driving more people to require home-based care.
Massive shortages in qualified staff are stretching hospitals and clinics beyond capacity.
About half of all American adults have one or more preventable chronic disease.
% of Americans live in rural areas with no access to healthcare.
% of clinician appointments could be done through telehealth.
Remosense is a clinical-grade, smart, handheld device allowing patients to collect accurate and precise measurements on key vital signs anywhere and instantly relay them to their clinician.
Remosense enables the right care at the right time by providing our
users with a complete integrated platform.
Remosense measures 7 different vital signs with high accuracy, all in one compact, reliable, and clinical-grade device. All data is transmitted via a secure app and stored in our HIPAA, GDPR, ISO compliant cloud.
Remosense provides clinicians with actionable clinical insights that allows them to pinpoit signs of deterioration and quickly direct care.
Telebionix has been recognized as a leader in MedTech
Cardiac Surgeon and Biosignal Researcher at the University of Zurich